Jan. 25, 2007 - Cardinal Health said it will sell its pharmaceutical technologies and services businesses to the Blackstone Group, a private equity firm, for about $3.3 billion in cash. Cardinal announced plans to divest the business in November 2006 in order to focus its full attention and resources on its supply chain and clinical products businesses. The pharmaceutical technologies and services unit develops, manufactures and packages medication and other products for pharmaceutical and biotech firms, employing approximately 10,000 people at more than 30 facilities and generating approximately $1.8 billion in revenue annually. The sale is expected to close sometime this summer in Cardinal’s fiscal fourth quarter. Cardinal said it plans to use the net proceeds to repurchase shares.
News | January 24, 2007
Cardinal Health to Sell Drug Devision
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
News | Mammography | June 29, 2017
GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable...
News | Breast Density | June 28, 2017
Stephen N. Birrell, M.D., Ph.D., presented breakthrough findings into the reduction of mammographic breast density at...
News | Mammography | June 23, 2017
June 23, 2017 — French radiology technology company Therapixel was recently named the winner of the Digital Mammograp
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
News | Mammography | June 08, 2017
An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are...
News | Mammography | June 07, 2017
Hologic, Inc. announced that the Genius 3D Mammography exam is now the only mammogram that is FDA-approved as superior...